Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-23T06:56:55.534Z Has data issue: false hasContentIssue false
  • English
  • Français

Le syndrome de sevrage des antidépresseurs

Published online by Cambridge University Press:  28 April 2020

M. Lejoyeux  and
J. Ades
M. Lejoyeux
Affiliation:
Service de psychiatrie du Pr T. Lempérière, hôpital Louis-Mourier, 92700 Colombes, France
J. Ades
Affiliation:
Service de psychiatrie du Pr T. Lempérière, hôpital Louis-Mourier, 92700 Colombes, France
Get access

Résumé

L'ensemble des signes cliniques survenant à l'arrêt d'un traitement antidépresseur a fait l'objet de nombreuses descriptions dans la littérature anglo-saxonne. La fréquence du syndrome de sevrage varie selon les auteurs. Les principaux types de trouble sont d'allure digestive ou pseudo-grippale. Un état anxieux, des perturbations du sommeil, des troubles moteurs et des épisodes maniaques ou hypomaniaques peuvent s'observer à l'arrêt d'un traitement antidépresseur tricyclique. Plus rarement apparaissent des attaques de panique, une confusion mentale ou bien une arythmie cardiaque. La plupart des antidépresseurs sont susceptibles d'induire un syndrome de sevrage. Les facteurs de risque d'apparition de ce syndrome ne sont pas précisément déterminés. Il semble néanmoins qu'un arrêt brutal d'un traitement comportant des doses élevees d'un antidépresseur à fort potentiel anticholinergique expose plus particulièrement aux signes de sevrage. Les traitements du sevrage proposés sont la reprise de l'antidépresseur ou bien la prescription de dérivés atropiniques. La prévention des signes de sevrage repose sur une diminution progressive des doses d'antidépresseurs. La pathogénie du trouble est une hyperactivité cholinergique ou une hyperstimulation noradrénergique. Enfin, les conséquences pratiques du syndrome de sevrage sont évoquées.

Summary

Summary

The antidepressant withdrawal syndrome has been described by many authors. The most common symptoms are general somatic or gastrointestinal distress, “flu-like syndrome”, anxiety, sleep disturbances, movement disorders, mania or hypomania, panic attacks, arrhythmia and delirium. The etiology of withdrawal symptoms is not fully known. In any case, abrupt discontinuation of high doses of cholinergic tricyclic antidepressants appears to be important. The most effective treatment could either be the reinstitution of an antidepressant drug or the administration of atropine sulphate or another tertiary belladonna alkaloid. Prevention of the withdrawal syndrome requires a gradual reduction of antidepressants. The biological mechanism of withdrawal syndromes appears to be related to “cholinergic overdrive” or noradrenergic hyperactivity. In conclusion, the clinical consequences and mode of prevention of the syndrome are discussed.

Keywords

sevrageantidépresseurstricycliqueswithdrawalantidepressanttrycyclics
Type
Revue
Information
Psychiatry and Psychobiology , Volume 4 , Issue 6 , 1989 , pp. 335 - 345
Copyright
Copyright © European Psychiatric Association 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Références

Andersen, H. & Kristiansen, E.S. (1959) Tofraniltreatment of endogenous depressions. Acta Psvchiatr. Neurol. Scarid. 34, 387–397CrossRefGoogle ScholarPubMed
Ben Arte, O. & George, G.C.W. (1979) A case of tranylcypromine («Parnate») addiction. Br. J. Psychiatry 135, 273–274CrossRefGoogle Scholar
Bigger, J.T.Giardina, E.G.V. & Perel, J.M. (1977) Cardiac antiarrhythmic effect of imipramine hydrochloride. N. Engl. J. Med. 296, 206–208CrossRefGoogle ScholarPubMed
Boisvert, D. & Chouinard, G. (1981) Rebound cardiac arrhythmia after withdrawal from imipramine: a case report. Am. J. Psychiatry 138, 325–329Google ScholarPubMed
Bradwejn, I.Jones, B.D. & Amiable, I.. (1982) Relapse or therapeutic rebound upon antidepressant withdrawal. Syllabus and Scientific Proceedings of the 135th Annual Meeting of the American Psychiatric Association, Washington DC, American Psychiatric AssociationGoogle Scholar
Brown, G.M.Stancer, H. C.Moldofsky, H.Harman, J.Murphy, J.T. & Gupta, R.N. (1978) Withdrawal from long-term high-dose desipramine therapy: clinical and biological changes. Arch. Gen. Psychiatry 35, 1261–1264CrossRefGoogle ScholarPubMed
Charney, D.S.Heninger, G. R.Steinberg, D. E.Redmond, D. E.Leckman, J. F.Maas, J.W. & Roth, R.H. (1981) Presynaptic adrenergic receptor sensitivity in depression. Arch. Gen. Psychiatry 38, 1334–1340CrossRefGoogle ScholarPubMed
Charney, D.S.Heninger, G. R.Sternberg, D.E. & Landis, H. (1982) Abrupt discontinuation of tricyclic antidepressant drugs: evidence for noradrenergic hyperactivity. Br. J. Psychiatry 141, 377–386CrossRefGoogle ScholarPubMed
Damluji, N.F. & Ferguson, J.M. (1988) Paradoxical worsening of depressive symptomatology caused by antidepressants. J. Clin. Psychopharmacology 8, 347–349CrossRefGoogle ScholarPubMed
De Montigny, C. & Aghajanian, G.K. (1978) Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 202, 1303–1306CrossRefGoogle ScholarPubMed
American Psychiatric Association (1987), Diagnostic and Statistical Manual of Mental Disorders, 3rd edition revised (DSM-III-R). Washington DCGoogle Scholar
Disalver, S. C, Kronfol, Z.Greden, J.F. & Sackellares, J.C. (1983a) Antidepressant withdrawal syndromes: evidences supporting the cholinergic overdrive hypothesis. J. Clin. Psychopharmucol. 3, 157–164Google Scholar
Disalver, S.C.Feinberg, M. & Greden, J.F. (1983b) Antidepressant withdrawal symptoms treated with anticholinergic agents. Am. J. Psychiatry 140, 249–251Google Scholar
Disalver, S.C. & Greden, J.F. (1984a) Antidepressant withdrawal phenomena. Biol. Psychiatry 19, 237–256Google Scholar
Disalver, S.C. & Greden, J.F. (1984b) Effect of antidepressant withdrawal on the dexamethasone suppression test. Psychiatry Res. 14, 111–122Google Scholar
Disalver, S. C, Greden, J.F. & Snider, R.M. (1987) Antidepressant withdrawal syndromes: phenomenology and physiopathology. Int. Clin. Psychopharmucol. 2, 1–19Google Scholar
Disalver, S.C. (1989) Antidepressant withdrawal syndromes phenomenology and pathophysiology. Acta Psychiatr. Scand. 79, 113–117Google Scholar
Dixon, W.R.Mosimann, W.F. & Weiner, R. (1979) The role of presynaptic feedback mechanisms in regulation of norepinephrine release by nerve stimulation. J. Pharmacol. Exp. Ther. 209, 196–204Google Scholar
Eggermont, E. (1973) Withdrawal symptoms in neonates associated with maternal imipramine therapy. Lancet ii, 680CrossRefGoogle Scholar
Garcia-Sevilla, J.A.Zis, A. P.Hollingsworth, P. J.Greden, J.F. & Smith, C.R. (1981) Platelet alpha adrenergic receptors in major depressive disorder. Arch. Gen. Psychiatry 38, 1327–1333Google ScholarPubMed
Gawin, F.H. & Markoff, R.A. (1981) Panic anxiety after abrupt discontinuation of amitriptyline. Am. J. Psychiatry 138, 117–118Google ScholarPubMed
Ghadirian, A.M. (1986) Paradoxical mood response following antidepressant withdrawal. Biol. Psychiatry 21, 1298–1300CrossRefGoogle ScholarPubMed
Ginestet, D.Cazas, O. & Braneiard, M. (1984) Deux cas de dépendance à l'aminepline. L'Euicéphule X, 189–191Google Scholar
R., Gittelman-Klein (1975) Pharmacotherapy and management of pathological separation anxiety. Int. J. Mental Health 4, 255–271Google Scholar
Classman, A.H. & Bigger, J. T, (1981) Cardiovascular effects of therapeutic doses of tricyclic antidepressants. Arch. Gen. Psychiatry 38, 815–820CrossRefGoogle Scholar
Gualtieri, C.T. & Staye, J. (1979) Withdrawal symptoms after abrupt cessation of amitriptyline in an eight-year old boy. Am. J. Psychiatry 136, 457–458Google Scholar
Iversen, L.L. & MacKay, AVP (1979) Pharmacodynamics of antidepressant drugs. In; Psychophurmucology of Affective Disorders (Paykel E.S. & Coppen A., eds.), Oxford University Press, New York, pp. 60–90Google Scholar
Jones, B.D.Steinberg, S. & Chouinard, G. (1984) Fastcycling bipolar disorder induced by withdrawal from long-term treatment with a tricyclic antidepressant. Am. J. Psychiatry 141, 108–109Google ScholarPubMed
Kramer, J.C.Klein, D.F. & Fink, M. (1961) Withdrawal symptoms following discontinuation of imipramine therapy. Am. J. Psychiatry 118, 549–550CrossRefGoogle Scholar
Law, W.Petti, T.A. & Kazdin, A. (1981) Withdrawal symptoms after graduated cessation of imipramine in children. Am. J. Psychiatry 118, 647–650Google Scholar
Le Gassicke, J.Ashcroft, G. W.Eccleston, D.Evans, J. I., Oswald 1. & Ritson, E.B. (1965) The clinical state, sleep and amine metabolism of a tranylcypromine (Parnate) addict. Br. J. Psychiatry 3, 357–364CrossRefGoogle Scholar
Lesser, J. (1983) Case report of withdrawal tardive dyskinesia associated with amoxapine. Am. J. Psychiatry 140, 1358–1359Google Scholar
Liskin, B.Roose, S. & Walsh, T. (1984) Acute psychosis following phenelzine discontinuation. J. Clin. Psychopharmucol. 5, 46—47Google Scholar
Lôo, H. & Olié, J.P. (1984) Problemes liés à l'arrêt des antidépresseurs et du lithium. Thérapie 39, 403–410Google Scholar
Mac Mahon, T.C. (1985) Bipolar affective symptoms associated with the use of captopril and abrupt withdrawal of pargyline and propranolol. Am. J. Psychiutry 142, 759–760Google Scholar
Mac Mahon, T.C. (1986) A clinical overview of syndromes following withdrawal of antidepressants. Hosp. Community Psychiutry 37, 883–884Google Scholar
Mann, A.M. & Mac Pherson, A. (1959) Clinical experience with imipramine (G22355) in the treatment of depression. Cun. Psychiutr. Assoc. J. 4, 38–47Google ScholarPubMed
Mirin, S.M.Schatzberg, A.F. & Creasey, D.E. (1981) Hypomania and mania after withdrawal of tricyclic antidepressants. Am. J. Psychiutry 138, 87–89Google ScholarPubMed
Nelson, J.CSchottenfield, R.S. & Condrad, E.D. (1983) Hypomania after desipramine withdrawal. Am. J. Psychiatry 140, 624–625Google ScholarPubMed
Palladino, A.S.R. (1983) Adverse reactions to abrupt discontinuation of phenelzine (letter). J. Clin. Psychophurmacol. 3, 206–207CrossRefGoogle Scholar
Petti, T.A. & Law, W. (1981) Abrupt cessation of highdose imipramine treatment in children. J. Am. Med. Assoc. 256, 768–779CrossRefGoogle Scholar
Pitt, B. (1974) Withdrawal symptoms after stopping phenelzine (letter). Br. Med. J. 2, 332–333CrossRefGoogle ScholarPubMed
Redmond, D.E. (1977) Alterations in the function of the nucleus locus ceeruleus: a possible model for studies of anxiety. In: Animal Models in Psychiutry and Neurology (Hanin I. & Usdin E., eds.), Pergamon Press, New York, pp. 294–304Google Scholar
Santos, A.B. Jr & Mc Curdy, L. (1980) Delirium after abrupt withdrawal from doxepin: case report. Am. J. Psychiutry 137, 239–240Google ScholarPubMed
Sathananthan, G.L. & Gershon, S. (1973) Imipramine withdrawal: an akathisia-like syndrome. Am. J. Psychiatry 130, 1286–1287CrossRefGoogle Scholar
Shatan, C. (1966) Withdrawal after abrupt termination of imipramine. Cun. Psychiutr. Assoc. J. (Suppl.) 150–158CrossRefGoogle Scholar
Siever, L.I. & Uhde, T.W. (1984) New studies and perspectives on the noradrenergic receptor system in depression. Biol. Psychiatry 19, 131–156Google ScholarPubMed
Snyder, S.H. & Yamamura, H.I. (1977) Antidepressants and the muscarinic acetylcholine receptor. Arch. Gen. Psychiutry 34, 236–239CrossRefGoogle ScholarPubMed
Stern, S.L. & Mendels, J. (1980) Withdrawal symptoms during the course of imipramine therapy. J. Clin. Psychiatry 41, 66–67Google Scholar
Trémine, T.Lauzel, J. P.Aigrot, S.Dubret, G. & Cousin, R. (1983) Un cas de toxicomanie à l'amineptine. Inf. Psychiatr. 59, 1187–1189Google Scholar
Tyrer, P. (1984) Clinical effects of abrupt withdrawal from tricyclic antidepressants and monoamine oxidase inhibitors after long-term treatment. J. Affective Dis. 6, 1–7CrossRefGoogle ScholarPubMed
Uhde, T.W.Siever, L. J.Post, R. M.Jimerson, D. C.Boulenger, J.P. & Buchsbaum, M.S. (1982) The relationship of plasma free MHPG to anxiety and psychophysical pain in normal volunteers. Psychopharmacol. Bull. 18, 129Google Scholar
U'Pritchard, D.C.Greenberg, D. A.Sheehan, P.P. & Snyder, S.H. (1978) Tricyclic antidepressants: therapeutic properties and affinity for alphanoradrenergic binding sites in the brain. Science 199, 197–198CrossRefGoogle Scholar
Weller, R.A. & McKnelly, W.V. (1983) Case report of withdrawal dyskinesia associated with amoxapine. Am. J. Psychiatry 140, 1515–1516Google ScholarPubMed
Yassa, R.Camille, Y. & Belzile, L. (1987) Tardive dyskinesia in the course of antidepressant therapy: a prevalence study and a review of the literature. J. Clin. Psychopharmacology 7, 243–246CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.